Milanova Tsveta
Known title: Chief Commercial OfficerCIK: 0001957180
Associated companies
Transaction History
| AGIO | ▲ Buy | Option Exercise | 8,500 | $0 | 4/2/2026 | View on chart |
| AGIO | ▼ Sell | Open Market | 3,262 | $113K | 4/2/2026 | View on chart |
| AGIO | ▲ Buy | Option Exercise | 5,666 | $0 | 3/2/2026 | View on chart |
| AGIO | ▼ Sell | Open Market | 1,681 | $49K | 3/2/2026 | View on chart |
| AGIO | ▲ Buy | Option Exercise | 4,000 | $0 | 3/2/2026 | View on chart |
| AGIO | ▼ Sell | Open Market | 1,187 | $34K | 3/2/2026 | View on chart |
| AGIO | ▲ Buy | Option Exercise | 8,475 | $0 | 1/5/2026 | View on chart |
| AGIO | ▼ Sell | Open Market | 2,872 | $78K | 1/5/2026 | View on chart |
| AGIO | ▲ Buy | Option Exercise | 6,000 | $0 | 12/30/2025 | View on chart |
| AGIO | ▼ Sell | Open Market | 2,932 | $79K | 12/30/2025 | View on chart |
| AGIO | ▲ Buy | Option Exercise | 6,000 | $0 | 6/24/2025 | View on chart |
| AGIO | ▼ Sell | Open Market | 2,770 | $93K | 6/24/2025 | View on chart |
| AGIO | ▼ Sell | Open Market | 1,681 | $60K | 3/3/2025 | View on chart |
| AGIO | ▲ Buy | Option Exercise | 5,667 | $0 | 3/1/2025 | View on chart |
| AGIO | ▼ Sell | Open Market | 2,804 | $90K | 1/6/2025 | View on chart |
| AGIO | ▲ Buy | Option Exercise | 8,476 | $0 | 1/3/2025 | View on chart |
| AGIO | ▼ Sell | Open Market | 1,618 | $35K | 1/24/2024 | View on chart |
| AGIO | ▲ Buy | Option Exercise | 5,448 | $0 | 1/20/2024 | View on chart |
| AGIO | ▼ Sell | Open Market | 2,902 | $65K | 1/5/2024 | View on chart |
| AGIO | ▲ Buy | Option Exercise | 8,475 | $0 | 1/3/2024 | View on chart |
| AGIO | ▼ Sell | Open Market | 1,618 | $46K | 6/30/2023 | View on chart |
| AGIO | ▲ Buy | Option Exercise | 5,449 | $0 | 6/28/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
AGIO Valuation Concerns Ahead of Q3 2026 Call
AGIO’s November earnings call sparked debate that the shares might be undervalued by about 28%, while analysts noted the stock appears fully priced against current sales. The company will host its third‑quarter 2026 results call on Nov. 5, which could clarify expectations. After a 29% decline over three months, Truist Securities lowered its target price to $37, reflecting a more cautious view.
AGIO Valuation Concerns Ahead of Q3 2026 Call. AGIO’s November earnings call sparked debate that the shares might be undervalued by about 28%, while analysts noted the stock appears fully priced against current sales. The company will host its third‑quarter 2026 results call on Nov. 5, which could clarify expectations. After a 29% decline over three months, Truist Securities lowered its target price to $37, reflecting a more cautious view.